US.RMD · ResMed

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.8089541704635725,
        "turnoverUsdM": 325.00569626927603,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.8,
    "stopLevels": {
      "symbol": "US.RMD",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 211.4442,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 3,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.7,
      "stop_loss_percent": 5.6,
      "take_profit_price": 245.7195,
      "target_multiplier": 2.2,
      "technical_strength": 2.35,
      "take_profit_percent": 9.7
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.7266212638846954,
    "stopLossPercent": 5.617908340927145,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 95.5,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 73.5,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 22
  },
  "market": {
    "ma20": 204.343,
    "ma50": 199.9312,
    "close": 224.03,
    "prevClose": 223.14,
    "avgVolume20": 1285711,
    "volumeRatio": 1.13,
    "changePercent": 0.4
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 22,
    "details": {
      "ret_5d": 0.04545246840508055,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 22,
      "vcp_bonus": 0,
      "vol_ratio": 1.1148566971370166,
      "ret_points": 8,
      "vol_points": 2,
      "range_ratio": 0.6748903241165127,
      "volat_points": 0,
      "day_range_pct": 0.02008659563489977,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 8,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": true,
      "return_window_days": 5,
      "first_breakout_bonus": 2,
      "breakout_quality_points": 1
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 95.5,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 5,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 100,
        "contribution": 5
      },
      {
        "raw": 17.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 86,
        "contribution": 17.2
      },
      {
        "raw": 9.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 64,
        "contribution": 9.6
      },
      {
        "raw": 6,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 7.2,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 72,
        "contribution": 7.2
      },
      {
        "raw": 22.5,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 75,
        "contribution": 22.5
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "謹慎買入",
    "result": 73.5,
    "details": [
      "基本面分析總分: 5/5分",
      "資金流分析總分: 17.2/20分",
      "市場環境分析總分: 9.6/15分",
      "催化劑分析: 6/20分",
      "風險管理總分: 7.2/10分",
      "技術信號分析總分: 22.5/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 6,
      "基本面": 5,
      "資金流": 17.2,
      "市場環境": 9.6,
      "情緒分析": 6,
      "技術信號": 22.5,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 1
            }
          },
          "catalystPoints": 6
        }
      },
      "基本面": {
        "max": 5,
        "grade": "優秀",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.4,
          "epsPoints": 0.75,
          "roePoints": 0.75,
          "debtPoints": 0.5,
          "marginPoints": 0.75,
          "turnoverUsdM": 325.00569626927603,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "優秀",
        "items": {
          "cmfPoints": 4,
          "mfiPoints": 3.2,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.RMD",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 16.5
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 700.8949957500001,
                "ma50": 715.00840014,
                "name": "QQQ",
                "close": 717.29999,
                "points": 1.4
              },
              "spy": {
                "ma20": 748.41450165,
                "ma50": 746.3736035600002,
                "name": "SPY",
                "close": 769.78998,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.8089541704635725,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 4,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141122755,
                "url": "https://finnhub.io/api/news?id=679dc62b0d6341e0716993d69a4659ffa37cff052797d6fbc10f1828108e701d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Evaluate the expected performance of ResMed (RMD) for the quarter ended June 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
                "category": "company",
                "datetime": 1785935706,
                "headline": "Curious about ResMed (RMD) Q4 Performance? Explore Wall Street Estimates for Key Metrics"
              },
              {
                "id": 141067141,
                "url": "https://finnhub.io/api/news?id=2eba5c1a1a25c1b0f492d696ae339d2d6665a3f0234260cb85aab3bb8fd081ad",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1785420019,
                "headline": "ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth"
              },
              {
                "id": 140907889,
                "url": "https://finnhub.io/api/news?id=cbbc8a208dad1164a764fe1bf8c2fbc264cb3db72fa3d2cf377033fa4545b99a",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "RMD",
                "summary": "Discover how the Best Dividend Stocks screen identifies sustainable payers like ResMed (RMD), combining high dividend ratings with strong profitability and health ratings for long-term stability.",
                "category": "company",
                "datetime": 1784119828,
                "headline": "ResMed Inc (NYSE:RMD) Offers a Quality Dividend Built on Strong Profitability and Financial Health"
              },
              {
                "id": 140886292,
                "url": "https://finnhub.io/api/news?id=0bb615d0359f2e54b7ebb837a70329209bcebadfe6eaa900635dfa26041c609e",
                "image": "",
                "source": "Fintel",
                "related": "RMD",
                "summary": "",
                "category": "company",
                "datetime": 1783950457,
                "headline": "Citigroup Downgrades ResMed (RMD)"
              },
              {
                "id": 140860771,
                "url": "https://finnhub.io/api/news?id=858a6da75138854abd8915ea5940529b05d135a5b4a8ee6d17bbe4273c781728",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (NYSE:RMD) has agreed to divest its MatrixCare business to a private equity buyer. The deal centers on refocusing the company around its sleep and respiratory health technologies and connected care platform. The transaction reflects a move away from post acute care software toward ResMed's core medical device and digital health operations. For investors watching ResMed, the exit from MatrixCare marks a clear effort to tighten the company’s focus on sleep apnea, respiratory care...",
                "category": "company",
                "datetime": 1783682044,
                "headline": "ResMed (RMD) Sells MatrixCare To Refocus On Sleep And Respiratory Health"
              },
              {
                "id": 140839354,
                "url": "https://finnhub.io/api/news?id=3afbd9f7767339b3fa20d89a28c07bc6c52ff41b828bd687f4b4cc381cb8902d",
                "image": "https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp",
                "source": "ChartMill",
                "related": "RMD",
                "summary": "Explore ResMed (RMD) as a quality investment with 68.2% ROIC, 92% cash conversion, low leverage, and 15.82% EBIT growth, scoring 8/10 in fundamentals.",
                "category": "company",
                "datetime": 1783509625,
                "headline": "ResMed Inc (NYSE:RMD) Builds on a Quality Foundation with Strong Profitability and Cash Conversion"
              },
              {
                "id": 140833227,
                "url": "https://finnhub.io/api/news?id=47f4aea8f162f415e7bade0e0ca4aa5eacad9d1ea8b187b386004a29294462b5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1783440603,
                "headline": "Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?"
              },
              {
                "id": 140831669,
                "url": "https://finnhub.io/api/news?id=b079e1138994c7ba217e646265e7984c87f06bd72fecc39e29111c4afb8e0940",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (RMD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.",
                "category": "company",
                "datetime": 1783435140,
                "headline": "ResMed (RMD) Soars 4.2%: Is Further Upside Left in the Stock?"
              }
            ],
            "raw_source": [
              {
                "id": 141125710,
                "url": "https://finnhub.io/api/news?id=908443464c6dac93d7d144bad74f909237b4d1ce507acfbe554ffe8dd66c08d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Inspire Medical's vast sleep apnea opportunity, rising margins and debt-free balance sheet support patience as reimbursement issues weigh on procedures.",
                "category": "company",
                "datetime": 1785952740,
                "headline": "Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?"
              },
              {
                "id": 141125711,
                "url": "https://finnhub.io/api/news?id=86654da613505d37a72deed55f1f4b51cbc7a004fc7b41b9e6fd5f1e19cb0c5a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Inspire Medical shares jumped 28.1% as an earnings beat, raised 2026 guidance and estimate revisions offset reimbursement pressure.",
                "category": "company",
                "datetime": 1785951300,
                "headline": "INSP's 28.1% Past-Month Rally Raises a Key Question for Investors"
              },
              {
                "id": 141122934,
                "url": "https://finnhub.io/api/news?id=5ebdc3970abbb2a2338a21c3afa648199e0f3a8e8c03b36dd04d8ac65b339e0d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Globus Medical and Resmed enter the earnings season with growth drivers intact despite tariff, inflation and hospital spending pressures.",
                "category": "company",
                "datetime": 1785941820,
                "headline": "What to Expect From These 2 MedTech Stocks This Earnings Season?"
              },
              {
                "id": 141122755,
                "url": "https://finnhub.io/api/news?id=679dc62b0d6341e0716993d69a4659ffa37cff052797d6fbc10f1828108e701d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Evaluate the expected performance of ResMed (RMD) for the quarter ended June 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
                "category": "company",
                "datetime": 1785935706,
                "headline": "Curious about ResMed (RMD) Q4 Performance? Explore Wall Street Estimates for Key Metrics"
              },
              {
                "id": 141104327,
                "url": "https://finnhub.io/api/news?id=352cc05ac2d4a26c5635f6fdf97bc1040f7f84f82a959edb3181f428a871c81d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Viemed Healthcare (VMD) delivered earnings and revenue surprises of -30.00% and +0.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785797109,
                "headline": "Viemed Healthcare, Inc. (VMD) Lags Q2 Earnings Estimates"
              },
              {
                "id": 141103236,
                "url": "https://finnhub.io/api/news?id=124e694ad0b3e2f69b544333b87c4d5251ef48d8bf142f9f9ca9f8ba16d24cdb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.",
                "category": "company",
                "datetime": 1785788962,
                "headline": "1 Cash-Producing Stock on Our Watchlist and 2 We Find Risky"
              },
              {
                "id": 141079192,
                "url": "https://finnhub.io/api/news?id=ba7731a4b95a73e9b539fb9155adffe31e1dea22943a4c45be8f8fa12e57990b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "RMD's Q4 results may reflect strong mask and device demand, portfolio innovation, acquisitions and digital health growth, with EPS seen rising 13.7%.",
                "category": "company",
                "datetime": 1785504720,
                "headline": "Resmed's Q4 Earnings on Deck: What's in Store for the Stock?"
              },
              {
                "id": 141078062,
                "url": "https://finnhub.io/api/news?id=eccab60418f61c40d3a156f57c0957bf7084f81ce29971339390e78da2a7b84d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.",
                "category": "company",
                "datetime": 1785504709,
                "headline": "3 Large-Cap Stocks to Consider Right Now"
              },
              {
                "id": 141067141,
                "url": "https://finnhub.io/api/news?id=2eba5c1a1a25c1b0f492d696ae339d2d6665a3f0234260cb85aab3bb8fd081ad",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1785420019,
                "headline": "ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth"
              },
              {
                "id": 141065678,
                "url": "https://finnhub.io/api/news?id=627351a5866f253bd786f5ad7587b3fed6c6ee8ec3bbe68f04ebc325dd60a5ac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Baxter (BAX) delivered earnings and revenue surprises of +55.56% and +5.95%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785414903,
                "headline": "Baxter International (BAX) Surpasses Q2 Earnings and Revenue Estimates"
              },
              {
                "id": 140991410,
                "url": "https://finnhub.io/api/news?id=a7d3773d8f60001c539390370a53abf66180cc30e499445d40c79aec749bde17",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "A clean balance sheet can signal disciplined management and stability. It also means a company can expand and thrive without relying on borrowed capital.",
                "category": "company",
                "datetime": 1784791489,
                "headline": "3 Cash-Heavy Stocks to Research Further"
              },
              {
                "id": 140973578,
                "url": "https://finnhub.io/api/news?id=d1da9496c35a7b3d8bb71682a817d89804339dc66aec5bf1446d9a2e13a70166",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (RMD) is expected to post strong fiscal Q4 earnings growth, helped by an 8.6% rise in sales a",
                "category": "company",
                "datetime": 1784653509,
                "headline": "ResMed Earnings Growth Seen Strong as Ventilator Issue Clouds FY27, UBS Says"
              },
              {
                "id": 140919724,
                "url": "https://finnhub.io/api/news?id=10d75e966d521449cb435e791208bb5a18a79c4ff41421920a9bd92a572ae747",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "SpaceX initiated, Lululemon downgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1784208834,
                "headline": "SpaceX initiated, Lululemon downgraded: Wall Street's top analyst calls"
              },
              {
                "id": 140915096,
                "url": "https://finnhub.io/api/news?id=d54ea0e2611a9220a67326b3f5a2746c38f64336c0ec6ee0731941b9e851e380",
                "image": "",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "Mizuho  analyst Anthony Petrone   maintains ResMed (NYSE:RMD) with a Outperform and lowers the price target from $235 to $220.",
                "category": "company",
                "datetime": 1784125957,
                "headline": "Mizuho Maintains Outperform on ResMed, Lowers Price Target to $220"
              },
              {
                "id": 140907889,
                "url": "https://finnhub.io/api/news?id=cbbc8a208dad1164a764fe1bf8c2fbc264cb3db72fa3d2cf377033fa4545b99a",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "RMD",
                "summary": "Discover how the Best Dividend Stocks screen identifies sustainable payers like ResMed (RMD), combining high dividend ratings with strong profitability and health ratings for long-term stability.",
                "category": "company",
                "datetime": 1784119828,
                "headline": "ResMed Inc (NYSE:RMD) Offers a Quality Dividend Built on Strong Profitability and Financial Health"
              },
              {
                "id": 140896086,
                "url": "https://finnhub.io/api/news?id=314ee830610034b8e43e9f1ac6965abc1e3002ee4aa295e5d160599d325fc78b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.",
                "category": "company",
                "datetime": 1784024591,
                "headline": "2 Mid-Cap Stocks with Exciting Potential and 1 We Ignore"
              },
              {
                "id": 140886292,
                "url": "https://finnhub.io/api/news?id=0bb615d0359f2e54b7ebb837a70329209bcebadfe6eaa900635dfa26041c609e",
                "image": "",
                "source": "Fintel",
                "related": "RMD",
                "summary": "",
                "category": "company",
                "datetime": 1783950457,
                "headline": "Citigroup Downgrades ResMed (RMD)"
              },
              {
                "id": 140886507,
                "url": "https://finnhub.io/api/news?id=a8b2c8f3e5e344f2a19f19bcb2204a6733a8d0ebc0ff3860ce7fd67951f1bc98",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/13/Beijing--China---June-4--2023-Keysight-S.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "Wall Street analysts change outlook on top names. Complete view of analyst rating changes including upgrades/downgrades. See analyst ratings page.",
                "category": "company",
                "datetime": 1783930266,
                "headline": "Keysight To Rally Over 24%? Here Are 10 Top Analyst Forecasts For Monday"
              },
              {
                "id": 140891790,
                "url": "https://finnhub.io/api/news?id=bc4c0c3007cde3881e550b7f3efaa125581edccfa93f7a00f5d3af4a166d5614",
                "image": "",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "Citigroup  analyst Laura Sutcliffe   downgrades ResMed (NYSE:RMD) from Buy to Neutral and lowers the price target from $270 to $235.",
                "category": "company",
                "datetime": 1783928623,
                "headline": "Citigroup Downgrades ResMed to Neutral, Lowers Price Target to $235"
              },
              {
                "id": 140864462,
                "url": "https://finnhub.io/api/news?id=5385dfbf612f8c20c2fd190bec7ce1355e17190a56528ddafaab67d9a11bf432",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "RMD's MatrixCare sale sharpens its focus on sleep, breathing and connected care while freeing resources for AI-powered digital health.",
                "category": "company",
                "datetime": 1783702260,
                "headline": "Resmed Divests MatrixCare Business to Sharpen Focus on Connected Care"
              },
              {
                "id": 140865835,
                "url": "https://finnhub.io/api/news?id=8a7c944eda02bc801c68e21fd610a333f48ce8899b9f4f1d5649f08ccdc90242",
                "image": "",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "Jefferies  analyst Matthew Taylor   maintains ResMed (NYSE:RMD) with a Hold and lowers the price target from $240 to $225.",
                "category": "company",
                "datetime": 1783693977,
                "headline": "Jefferies Maintains Hold on ResMed, Lowers Price Target to $225"
              },
              {
                "id": 140860771,
                "url": "https://finnhub.io/api/news?id=858a6da75138854abd8915ea5940529b05d135a5b4a8ee6d17bbe4273c781728",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (NYSE:RMD) has agreed to divest its MatrixCare business to a private equity buyer. The deal centers on refocusing the company around its sleep and respiratory health technologies and connected care platform. The transaction reflects a move away from post acute care software toward ResMed's core medical device and digital health operations. For investors watching ResMed, the exit from MatrixCare marks a clear effort to tighten the company’s focus on sleep apnea, respiratory care...",
                "category": "company",
                "datetime": 1783682044,
                "headline": "ResMed (RMD) Sells MatrixCare To Refocus On Sleep And Respiratory Health"
              },
              {
                "id": 140855906,
                "url": "https://finnhub.io/api/news?id=b01a63fb4c3f6bb23434e162ac8caff70a1b9818d14462603d281dbcdf6edc22",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed is scheduled to post its fourth-quarter results soon, and analysts project a double-digit earnings growth.",
                "category": "company",
                "datetime": 1783610490,
                "headline": "ResMed's Q4 2026 Earnings: What to Expect"
              },
              {
                "id": 140852299,
                "url": "https://finnhub.io/api/news?id=f510a7398e32584659099b560b5a3e238c433e7fa50b01dfea03c0f42e65489d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Opportunities in the medical ventilators market include the rising demand for advanced respiratory care, driven by healthcare prioritization, technological advancements, and increased adoption of AI. Growth potential exists across product types, ventilation methods, and regions globally, offering innovation and expansion prospects. Medical Ventilators Market Medical Ventilators Market Dublin, July 09, 2026 (GLOBE NEWSWIRE) -- The \"Medical Ventilators Market\" has been added to ResearchAndMarkets.",
                "category": "company",
                "datetime": 1783608180,
                "headline": "Global Medical Ventilators Market Report 2025-2030 Just Released; Comprehensive Profiles of Getinge, Drägerwerk, Philips, Medtronic, and ResMed"
              },
              {
                "id": 140865836,
                "url": "https://finnhub.io/api/news?id=8429e6069e666f2257b05544805689110bc0d3086403cc3a58991b801b3ebdbe",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/09/Bradford--Uk-Oct-21-2025---Resmed-Airfit.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "ResMed is selling MatrixCare for $490 million to sharpen its sleep health focus as analysts weigh near-term EPS dilution against long-term growth.",
                "category": "company",
                "datetime": 1783605831,
                "headline": "ResMed Analyst Backs Portfolio Reset"
              },
              {
                "id": 140844149,
                "url": "https://finnhub.io/api/news?id=9484d20aa61c6c942da1a1e7dbb1f6c6d40534e1ecae5914006ae223b640bd3c",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "RMD",
                "summary": "Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.",
                "category": "company",
                "datetime": 1783537501,
                "headline": "What's going on in today's session: S&P500 movers"
              },
              {
                "id": 140841131,
                "url": "https://finnhub.io/api/news?id=184ab29f606db1393fafdf742f7523325b403b70a7618e1fc5906c3e35970cdd",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "RMD",
                "summary": "Wednesday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.",
                "category": "company",
                "datetime": 1783521301,
                "headline": "Gapping S&P500 stocks in Wednesday's session"
              },
              {
                "id": 140840675,
                "url": "https://finnhub.io/api/news?id=51fce926dd180929265eefc61c478d1cb5ef9dc8c38ee7cd2be80e8da4b8ea79",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Resmed’s decision to sell MatrixCare to PE firm Frazier Healthcare Partners comes less than a decade after its $750m acquisition of the software business.",
                "category": "company",
                "datetime": 1783518814,
                "headline": "Resmed sharpens sleep care focus with $490m software business sale"
              },
              {
                "id": 140841616,
                "url": "https://finnhub.io/api/news?id=961c0a32e8a2697dab9deacd629e37f144c77ccb61b2833357916b0c6031e247",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Oil prices spiked following an exchange of strikes between the US and Iran",
                "category": "company",
                "datetime": 1783512720,
                "headline": "Dow Jones and Nasdaq start lower as Trump says Iran ceasefire 'over'"
              },
              {
                "id": 140840676,
                "url": "https://finnhub.io/api/news?id=8d960c3782da5a91b3b391f90f39a6afa839dd8a5d8d3c6e8eaf634a8e15890a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is one of the 10 Best Stocks to Buy in Glen Kacher’s Light Street Portfolio. As of the quarter ended March 31, 2026, Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) represents 14.40% of Glen Kacher’s Light Street Portfolio. Additionally, the fund holds a put option position valued at $36,904,140 in […]",
                "category": "company",
                "datetime": 1783512037,
                "headline": "Here is why Taiwan Semiconductor (TSM) Is Among the Best Stocks in Glen Kacher’s Portfolio"
              },
              {
                "id": 140843595,
                "url": "https://finnhub.io/api/news?id=f36a92998aa80531ab0c9af7f1339622323e9b3d2ec1fb8340e8b260d514bfcf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Selling the software business to Frazier Healthcare Partners will allow the respiratory device maker to shift more resources to faster-growing parts of its portfolio.",
                "category": "company",
                "datetime": 1783510121,
                "headline": "Resmed to sell MatrixCare for $490M to private equity firm"
              },
              {
                "id": 140839354,
                "url": "https://finnhub.io/api/news?id=3afbd9f7767339b3fa20d89a28c07bc6c52ff41b828bd687f4b4cc381cb8902d",
                "image": "https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp",
                "source": "ChartMill",
                "related": "RMD",
                "summary": "Explore ResMed (RMD) as a quality investment with 68.2% ROIC, 92% cash conversion, low leverage, and 15.82% EBIT growth, scoring 8/10 in fundamentals.",
                "category": "company",
                "datetime": 1783509625,
                "headline": "ResMed Inc (NYSE:RMD) Builds on a Quality Foundation with Strong Profitability and Cash Conversion"
              },
              {
                "id": 140842216,
                "url": "https://finnhub.io/api/news?id=2f7a1ff383958c9c588f0b4d6f1cf0891ac3c2a77f28bded05a968c88ef17588",
                "image": "",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "RBC Capital  analyst Craig Wong-Pan   maintains ResMed (NYSE:RMD) with a Outperform and lowers the price target from $321 to $276.",
                "category": "company",
                "datetime": 1783504730,
                "headline": "RBC Capital Maintains Outperform on ResMed, Lowers Price Target to $276"
              },
              {
                "id": 140839472,
                "url": "https://finnhub.io/api/news?id=dd881bcabc2bb19487918ffbc9709eff68916225493c5faeff1ce53c02d8bc5e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2220524615/image_2220524615.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "RMD",
                "summary": "I track a curated universe of 50 high-quality dividend growth stocks to identify opportune entry points based on valuation and future return potential.",
                "category": "company",
                "datetime": 1783496560,
                "headline": "Top 50 High-Quality Dividend Growth Stocks For July 2026"
              },
              {
                "id": 140842217,
                "url": "https://finnhub.io/api/news?id=457494ae071b981249745466f721de9ca30b10d74e7f85d0a9430930dd0bd10a",
                "image": "",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "Wells Fargo  analyst Nathan Treybeck   maintains ResMed (NYSE:RMD) with a Equal-Weight and lowers the price target from $227 to $225.",
                "category": "company",
                "datetime": 1783492862,
                "headline": "Wells Fargo Maintains Equal-Weight on ResMed, Lowers Price Target to $225"
              },
              {
                "id": 140836642,
                "url": "https://finnhub.io/api/news?id=7150608e7a1e9da2b05e95f7d7a3da9950ee9702811ea6d505349d11cbd43fa0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed said on Tuesday it would sell its software business MatrixCare to private equity firm Frazier ‌Healthcare Partners for $490 million in cash, as the health ‌technology company sharpens its focus on sleep, breathing and home-based care.  ResMed, which makes devices ​to manage sleep apnea, said it plans to use the net proceeds to return capital to shareholders, including through an accelerated share repurchase program, and for general corporate purposes.",
                "category": "company",
                "datetime": 1783462022,
                "headline": "ResMed to sell software business MatrixCare for $490 million"
              },
              {
                "id": 140835528,
                "url": "https://finnhub.io/api/news?id=047c4127a3c3248f9b7de0b015476ac93f194ea7bb479e5746c6f05c1623fffa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "SEATTLE, July 07, 2026--Frazier Healthcare Partners (\"Frazier\"), a private equity firm focused exclusively on the healthcare industry, today announced it has entered into a definitive agreement to acquire MatrixCare (the \"Company\") from Resmed (NYSE & ASX: RMD).",
                "category": "company",
                "datetime": 1783458360,
                "headline": "Frazier Healthcare Partners Announces Definitive Agreement to Acquire MatrixCare"
              },
              {
                "id": 140835529,
                "url": "https://finnhub.io/api/news?id=e7596b4f257014f4536ff58cfa77882afa111248dbe8eea765ca40f136a481a4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "Sharpens Resmed’s focus on high-growth sleep and connected care marketsSAN DIEGO, July 07, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners, a private equity firm focused exclusively on health care. This move reflects Resmed’s 2030 strategy by focusing on high-growth, scala",
                "category": "company",
                "datetime": 1783456200,
                "headline": "Resmed Announces Agreement to Sell MatrixCare Business"
              },
              {
                "id": 140842218,
                "url": "https://finnhub.io/api/news?id=583f6ba7ccf408430afbbe2f2779b3e6ab535560fdf2f783ccd545b5ad6a8769",
                "image": "",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "On July 7, 2026, ResMed Inc. (the "Company" or "Resmed") issued a press release announcing that on June 30, 2026 it entered into a definitive agreement to sell its MatrixCare business to Frazier",
                "category": "company",
                "datetime": 1783445352,
                "headline": "ResMed Says Deal Valued At $490M All-Cash, Expected To Close In Q1 FY2027"
              },
              {
                "id": 140842219,
                "url": "https://finnhub.io/api/news?id=7f4fe098da525af43ace0d7f8e94d1757a97f27f17c53dfddce118182ab1d78f",
                "image": "",
                "source": "Benzinga",
                "related": "RMD",
                "summary": "Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has entered into a definitive agreement to sell its MatrixCare business",
                "category": "company",
                "datetime": 1783441955,
                "headline": "Resmed Strikes Agreement To Sell Its MatrixCare Operations To Frazier Healthcare Partners; Financial Terms Undisclosed"
              },
              {
                "id": 140833227,
                "url": "https://finnhub.io/api/news?id=47f4aea8f162f415e7bade0e0ca4aa5eacad9d1ea8b187b386004a29294462b5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1783440603,
                "headline": "Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?"
              },
              {
                "id": 140831669,
                "url": "https://finnhub.io/api/news?id=b079e1138994c7ba217e646265e7984c87f06bd72fecc39e29111c4afb8e0940",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RMD",
                "summary": "ResMed (RMD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.",
                "category": "company",
                "datetime": 1783435140,
                "headline": "ResMed (RMD) Soars 4.2%: Is Further Upside Left in the Stock?"
              },
              {
                "id": 140823274,
                "url": "https://finnhub.io/api/news?id=0a291e7c86c0a83d03304d27f309a48cc58fe1e3fe4da31fb9cc385ec9855e54",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "RMD",
                "summary": "Stay updated with the movements of the S&P500 index one hour before the close of the markets on Monday. Discover which stocks are leading as top gainers and losers in today's session.",
                "category": "company",
                "datetime": 1783364701,
                "headline": "Top S&P500 movers in Monday's session"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 4,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 43,
            "discarded_article_count": 35
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 22.5,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 1.4,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.4,
            "vcp_reason": "站上MA50；升放量(近10日2日)；收盤突破20日高位；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 7,
              "vol_ref": 1448576.6666666667,
              "down_days": 2,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1200750,
              "avg_vol_20": 1301265,
              "avg_vol_30": 1448576.6666666667,
              "range_pct_10": 0.14730170132259832,
              "range_pct_20": 0.14730170132259832,
              "range_pct_30": 0.1475249303554209,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 2,
              "breakout_20d_ok": true,
              "vol_ratio_10_30": 0.828917120944007,
              "dist_to_20d_high": -0.0036736210889466493,
              "down_shrink_days": 2,
              "breakout_level_20d": 223.21001,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.998486838581894
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 3.2,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.8089541704635725,
              "turnoverUsdM": 325.00569626927603,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.8,
          "stopLevels": {
            "symbol": "US.RMD",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 211.4442,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 3,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.7,
            "stop_loss_percent": 5.6,
            "take_profit_price": 245.7195,
            "target_multiplier": 2.2,
            "technical_strength": 2.35,
            "take_profit_percent": 9.7
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.7266212638846954,
          "stopLossPercent": 5.617908340927145,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 6.2929,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.81
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 169.97
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "強累積",
      "score": 10,
      "value": 0.3102
    },
    "kdj": {
      "d": 81.71,
      "j": 109.27,
      "k": 90.9,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 63.02
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 6101224,
      "recentSlope": 929222.4,
      "previousSlope": -830400
    },
    "rsi": 69.52,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 194.5449,
      "position": "SAR喺價下",
      "distancePct": 13.16,
      "previousTrend": "上升"
    },
    "ma50": 199.9312,
    "macd": {
      "macd": 5.084194605363535,
      "trend": "強烈看漲",
      "signal": 2.5919613566967348,
      "histogram": 2.4922332486668006
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 204.143,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 8
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.13,
      "score": 6,
      "avgVolume": 1285711,
      "currentVolume": 1450724
    },
    "derived": {
      "ma20": 204.343,
      "ma50": 199.9312,
      "prevClose": 223.14,
      "avgVolume10": 1248712,
      "avgVolume20": 1285711,
      "changePercent": 0.4,
      "avgVolumeForScore": 1285711
    },
    "ma_cross": {
      "ma20": 204.343,
      "ma50": 199.9312,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 203.4335,
      "prevMa50": 199.6116,
      "spreadPct": 2.21,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 185.5794,
      "upper": 223.1066,
      "position": "上半部"
    },
    "rsi_short": 78.4,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.13
    }
  }
}

{
  "close": 224.03,
  "volume": 1450724,
  "changePercent": 0.4
}